Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals.
about
Influenza vaccination in HIV-positive subjects: latest evidence and future perspectiveAssessment of antigen-specific and cross-reactive antibody responses to an MF59-adjuvanted A/H5N1 prepandemic influenza vaccine in adult and elderly subjects.Immunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth.High level antibody avidity is achieved in HIV-seropositive recipients of an inactivated split adjuvanted (AS03A) influenza vaccine.Durability of protective antibody titres is not enhanced by a two-dose schedule of an ASO3-adjuvanted pandemic H1N1 influenza vaccine in adult HIV-1-infected patients.Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for childrenInfluenza and HIV: lessons from the 2009 H1N1 influenza pandemic.Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients.Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.High-level immunogenicity is achieved vaccine with adjuvanted pandemic H1N1(2009) and improved with booster dosing in a randomized trial of HIV-infected adults.Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients.Immunogenicity and tolerability after two doses of non-adjuvanted, whole-virion pandemic influenza A (H1N1) vaccine in HIV-infected individuals.Immune response to 2009 H1N1 vaccine in HIV-infected adults in Northern Thailand.Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals.Representation of women and pregnant women in HIV research: a limited systematic review.Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy.Randomized Controlled Trial to Compare Immunogenicity of Standard-Dose Intramuscular Versus Intradermal Trivalent Inactivated Influenza Vaccine in HIV-Infected Men Who Have Sex With Men in Bangkok, Thailand.HIV-dependent depletion of influenza-specific memory B cells impacts B cell responsiveness to seasonal influenza immunisation.Immune response after a single dose of the 2010/11 trivalent, seasonal influenza vaccine in HIV-1-infected patients and healthy controls.Long-term seroprotective response of trivalent seasonal influenza vaccine in HIV-infected children, regardless of immunogenicity before immunisation.
P2860
Q27007483-B2856276-2834-4984-90B1-94ED12A2F2F1Q30223941-4543C3C5-9CCD-49D9-8314-73CFB4BDC9B2Q30357158-93583217-85AC-4238-BB54-2CADCE10D5A7Q30362521-5F00E4DB-CEFD-46DA-8068-51B813FCEA10Q30364472-BAD7B02D-6387-4957-8FB7-EB908314E57AQ30371111-11A89F9D-4CA9-4A41-8226-FAA6B1FA6DA5Q30404293-EDEA6EFB-C843-4B6A-88DD-957F5B97ABAEQ30409595-FC4E34D2-3926-46EC-A8C7-7E135C31BB88Q30412422-693D52F1-4E1A-4F5B-90EA-0C054FA6C074Q30412595-1E926DA8-89BE-48B8-AD09-A134F64636CBQ30414543-69170782-C80B-40B9-B63C-575924911B5AQ30417245-DA384787-08DD-46D2-8B19-46DF5D7A0C82Q30420476-F7E5C5E9-F6DB-4726-A77A-6C38BD5AA985Q30420821-1DF471C2-8B44-4A7A-A8A2-BEB3E18B434AQ34979789-2CFEE194-2471-4282-881F-6EC72E9B8307Q35207950-9C9F85A2-75CF-4926-8FF6-E6A7B03F7668Q36447589-98047131-1F9D-4169-94D7-190707405C6DQ36933809-73ED8C20-2205-49AF-BAB9-C858E9573055Q38446730-F80E13E9-E694-436B-AA36-4B38652D4771Q41125999-62A5AE1A-DBB6-4812-8575-92676E73B745
P2860
Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Induction of protective antibo ...... in HIV-1-infected individuals.
@ast
Induction of protective antibo ...... in HIV-1-infected individuals.
@en
type
label
Induction of protective antibo ...... in HIV-1-infected individuals.
@ast
Induction of protective antibo ...... in HIV-1-infected individuals.
@en
prefLabel
Induction of protective antibo ...... in HIV-1-infected individuals.
@ast
Induction of protective antibo ...... in HIV-1-infected individuals.
@en
P2093
P50
P1433
P1476
Induction of protective antibo ...... in HIV-1-infected individuals.
@en
P2093
Alessandro Monti
Gabriele Pellicciotta
Laura Galli
Matteo Moro
Paolo Mascagni
P304
P356
10.1097/QAD.0B013E328341AFA8
P407
P577
2011-01-01T00:00:00Z